Gorden K - Search Results

1

Retroviral-mediated transfer of the murine interleukin-3 gene engineered for intracellular retention results in a myeloproliferative syndrome but is associated with circulating interleukin-3 levels.

Orchard PJ, Detrick RA, Gorden K, Dunbar CE, Vallera DA, Taylor P, McIvor RS, Blazar BR. Orchard PJ, et al. Among authors: gorden k. Exp Hematol. 1993 Aug;21(9):1245-54. Exp Hematol. 1993. PMID: 8330649

2

Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors.

Katsanis E, Orchard PJ, Bausero MA, Gorden KB, McIvor RS, Blazar BR. Katsanis E, et al. Among authors: gorden kb. J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):81-90. doi: 10.1097/00002371-199402000-00001. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8136949

3

The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties.

Boyer MW, Vallera DA, Taylor PA, Gray GS, Katsanis E, Gorden K, Orchard PJ, Blazar BR. Boyer MW, et al. Among authors: gorden k. Blood. 1997 May 1;89(9):3477-85. Blood. 1997. PMID: 9129056 Free article.

4

B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.

Katsanis E, Xu Z, Bausero MA, Dancisak BB, Gorden KB, Davis G, Gray GS, Orchard PJ, Blazar BR. Katsanis E, et al. Among authors: gorden kb. Cancer Gene Ther. 1995 Mar;2(1):39-46. Cancer Gene Ther. 1995. PMID: 7542553

5

Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of an in vivo CD8+ T-cell immune response to murine myeloid leukemia.

Boyer MW, Orchard PJ, Gorden KB, Anderson PM, Mclvor RS, Blazar BR. Boyer MW, et al. Among authors: gorden kb. Blood. 1995 May 1;85(9):2498-506. Blood. 1995. PMID: 7727779 Free article.

6

The isocitrate dehydrogenase phosphorylation cycle. Identification of the primary rate-limiting step.

Stueland CS, Gorden K, LaPorte DC. Stueland CS, et al. Among authors: gorden k. J Biol Chem. 1988 Dec 25;263(36):19475-9. J Biol Chem. 1988. PMID: 3058700 Free article.

7

Immunoglobulin Restores Immune Responses to BTH1677 in Patients With Low Levels of Antibodies to Beta-glucan.

Hurley PJ, Bose N, Jha G, Gargano M, Ottoson N, Gorden K, Rathmann B, Harrison B, Qiu X, Dudek AZ. Hurley PJ, et al. Among authors: gorden k. Anticancer Res. 2020 Mar;40(3):1467-1473. doi: 10.21873/anticanres.14090. Anticancer Res. 2020. PMID: 32132045

8

Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers.

Bose N, Ottoson NR, Qiu X, Harrison B, Lowe JR, Uhlik MT, Rathmann BT, Kangas TO, Jordan LR, Ertelt KE, Jonas AB, Walsh RM, Chan ASH, Fulton RB, Leonardo SM, Fraser KA, Gorden KB, Matson MA, Graff JR, Huhn RD. Bose N, et al. Among authors: gorden kb. J Immunol. 2019 May 15;202(10):2945-2956. doi: 10.4049/jimmunol.1801533. Epub 2019 Apr 15. J Immunol. 2019. PMID: 30988115 Clinical Trial.

9

A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer.

Thomas M, Sadjadian P, Kollmeier J, Lowe J, Mattson P, Trout JR, Gargano M, Patchen ML, Walsh R, Beliveau M, Marier JF, Bose N, Gorden K, Schneller F 3rd. Thomas M, et al. Among authors: gorden k. Invest New Drugs. 2017 Jun;35(3):345-358. doi: 10.1007/s10637-017-0450-3. Epub 2017 Mar 16. Invest New Drugs. 2017. PMID: 28303530 Free PMC article. Clinical Trial.

10

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies.

Chan ASH, Kangas TO, Qiu X, Uhlik MT, Fulton RB, Ottoson NR, Gorden KB, Yokoyama Y, Danielson ME, Jevne TM, Michel KS, Graff JR, Bose N. Chan ASH, et al. Among authors: gorden kb. Front Oncol. 2022 May 26;12:869078. doi: 10.3389/fonc.2022.869078. eCollection 2022. Front Oncol. 2022. PMID: 35692755 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page